1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Assist Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Assist Devices Market, Canada
2.1 Cardiac Assist Devices Market, Canada, Revenue ($m), 2024-2036
2.1.1 Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.2 Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.3 Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036
2.2.1 Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.2 Mechanical Circulatory Support Devices Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.3 Short-Term Circulatory Support Devices Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Assist Devices Market, Canada, Average Price ($), 2024-2036
2.4 Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), 2025
3 Cardiac Assist Devices Market Pipeline Products
3.1 Cardiac Assist Devices Market Pipeline Products
3.2 Cardiac Assist Devices - Pipeline Products by Stage of Development
3.3 Cardiac Assist Devices - Pipeline Products by Segment
3.4 Cardiac Assist Devices - Pipeline Products by Territory
3.5 Cardiac Assist Devices - Pipeline Products by Regulatory Path
3.6 Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Cardiac Assist Devices Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Abiomed Inc
4.2.1 Company Overview
4.3 Getinge AB
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 LivaNova Plc
4.5.1 Company Overview
4.6 Terumo Corp
4.6.1 Company Overview
4.7 Teleflex Inc
4.7.1 Company Overview
4.8 Syncardia Systems LLC
4.8.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.1.2 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.1.3 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.1.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.1.5 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
5.1.6 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound
5.1.7 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.1.8 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement
5.1.9 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association
5.2 Government and Public Interest
5.2.1 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
5.3 Other Significant Developments
5.3.1 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.3.2 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.3.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.3.4 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
5.4 Product News
5.4.1 Nov 06, 2025: Agitated Solutions Enrolls First Patient in Phase 3 'Enhance' Trial of Novel Contrast Agent for Cardiac Bubble Studies
5.4.2 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome
5.4.3 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
5.4.4 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.4.5 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.4.6 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
5.4.7 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound
5.4.8 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.4.9 Oct 09, 2025: Asahi Kasei Achieves FDA Approval for ZOLL’s Zenix Monitor/Defibrillator
5.4.10 Sep 29, 2025: Sparrow BioAcoustics Joins Innovators' Network at American Heart Association
5.5 Strategy And Business Planning
5.5.1 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
5.5.2 Oct 30, 2025: OrganOx Completes Acquisition By Terumo Corporation
5.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.5.4 Oct 23, 2025: Sonus And Providence Health Care Ventures Strengthen Partnership For Clinical Validation Of Wearable Cardiac Ultrasound
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 4: Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 5: Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036
Table 6: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), 2024-2036
Table 7: Mechanical Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036
Table 8: Short-Term Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036
Table 9: Cardiac Assist Devices Market, Canada, Average Price ($), 2024-2036
Table 10: Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 11: Cardiac Assist Devices Market Pipeline Products
Table 12: Cardiac Assist Devices - Pipeline Products by Stage of Development
Table 13: Cardiac Assist Devices Companies - Pipeline Products by Stage of Development
Table 14: Cardiac Assist Devices - Pipeline Products by Segment
Table 15: Cardiac Assist Devices - Pipeline Products by Territory
Table 16: Cardiac Assist Devices - Pipeline Products by Regulatory Path
Table 17: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
Table 18: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Mechanical Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 4: Short-Term Circulatory Support Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 5: Cardiac Assist Devices Market, Canada, Volume (Units), 2024-2036
Figure 6: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), 2024-2036
Figure 7: Mechanical Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036
Figure 8: Short-Term Circulatory Support Devices Market, Canada, Volume (Units), 2024-2036
Figure 9: Cardiac Assist Devices Market, Canada, Company Share (%), 2025
Figure 10: Cardiac Assist Devices - Pipeline Products by Stage of Development
Figure 11: Cardiac Assist Devices - Pipeline Products by Segment
Figure 12: Cardiac Assist Devices - Pipeline Products by Territory
Figure 13: Cardiac Assist Devices - Pipeline Products by Regulatory Path
Figure 14: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
